AAMS Internal Medicine & Therapeutics · Vol. 7 · Issue 3 · 2026-03-01
SGLT2 Inhibitors and Cardiovascular Outcomes in Heart Failure With Preserved Ejection Fraction
Williams JD, Kang HW, Abdullayev T
Imperial College London, London, UK; Samsung Medical Center, Seoul, South Korea; Republican Specialized Cardiology Center, Tashkent, Uzbekistan
Abstract
Post-hoc analysis of a large multinational RCT examining the efficacy of SGLT2 inhibitors in 4,800 patients with heart failure with preserved ejection fraction across 18 countries.
Keywords: SGLT2 inhibitors, heart failure, HFpEF, cardiovascular outcomes
Full Text